Jane Street »

Transcode Therapeutics shares owned by Jane Street

Quarter-by-quarter ownership of Transcode Therapeutics (RNAZ) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Transcode Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Transcode Therapeutics held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Transcode Therapeutics by Jane Street

Quarter filed Position value Share count Share price at filing
2024-09-30 $23k 40k 0.57

More positions owned by Jane Street

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Put Option (MSFT)
Amazon Call Option (AMZN)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Spdr Gold Tr Gold Shs (GLD)
Advanced Micro Devices Call Option (AMD)
Pdd Holdings Sponsored Ads Put Option (PDD)
Broadcom Put Option (AVGO)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Jane Street

Top funds holding Transcode Therapeutics

Geode Capital Management
Sheets Smith Wealth Management
Jane Street
Private Capital Management
Captrust Financial Advisors
Two Sigma Securities
Morgan Stanley
Tower Research Capital
Bank of America Corporation

View all funds holding Transcode Therapeutics